CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study

Assessment of Senl_B19 CAR-T Cells in Relapsed/Refractory CD19+ B-ALL

NCT07244406 ·Status: RECRUITING ·Phase: PHASE2

Senl-h19 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT04792593 ·Status: UNKNOWN ·Phase: NA

Cell Therapy for CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD7-Specific CAR-T Cells

NCT04572308 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of CD22 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT04546906 ·Status: UNKNOWN ·Phase: NA

CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies

NCT03121625 ·Status: UNKNOWN ·Phase: PHASE1

Clinical Study of Multi-targeted CAR-T Therapy in Patients With Relapsed/Refractory B-Cell Lymphoma

NCT07093086 ·Status: WITHDRAWN ·Phase: PHASE1

Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours

NCT06238336 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ Lymphoma

NCT05212584 ·Status: UNKNOWN ·Phase: PHASE1

A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma

NCT05909527 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells

NCT06420076 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma

NCT04689659 ·Status: COMPLETED ·Phase: PHASE2

Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies

NCT06316427 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL

NCT05902845 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)

NCT05907603 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Study of Anti-CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma

NCT03692767 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL

NCT05716113 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Clinical Study of Universal CAR-γδT Cell Injection in the Treatment of Patients With Relapsed AML After Transplantation

NCT04796441 ·Status: UNKNOWN ·Phase: NA

A Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Hodgkin's Lymphoma

NCT04665063 ·Status: UNKNOWN ·Phase: NA

Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma

NCT03690310 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies

NCT05618041 ·Status: RECRUITING ·Phase: NA

A Study of C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's Lymphoma

NCT04696432 ·Status: COMPLETED ·Phase: PHASE1

CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma

NCT05948033 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies

NCT03312205 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

An Open and Dose-escalation Early Clinical Study of CD19 and CD20 CAR-T Cell Therapy for Relapsed or Refractory Aggressive B-cell Lymphoma

NCT07344818 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia

NCT04938115 ·Status: COMPLETED ·Phase: NA